{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:40Z","timestamp":1790916940390,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Uterine sarcomas represent a rare and heterogeneous group of malignancies whose management remains clinically challenging. They account for approximately 3%\u20135% of all uterine malignancies. Undifferentiated uterine sarcoma (UUS) is a subtype of uterine sarcomas.\n                    <jats:italic>SMARCA4<\/jats:italic>\n                    is a tumor suppressor gene that is aberrantly altered in approximately 5%\u20137% of human malignancies.\n                    <jats:italic>SMARCA4<\/jats:italic>\n                    -deficient UUS is a highly aggressive, undifferentiated mesenchymal neoplasm associated with a median overall survival (OS) of 7 months. During tumorigenesis, loss of function of either\n                    <jats:italic>SMARCA4<\/jats:italic>\n                    or\n                    <jats:italic>SMARCA2<\/jats:italic>\n                    is frequently observed; however, concurrent loss of both genes has been reported to be synthetically lethal and is therefore considered unexpected. In this case report, a 52-year-old Chinese woman with early-stage UUS and\n                    <jats:italic>SMARCA4<\/jats:italic>\n                    and\n                    <jats:italic>SMARCA2<\/jats:italic>\n                    co-deficiency underwent surgical resection followed by adjuvant chemotherapy and achieved a disease-free survival (DFS) of 32 months. This case suggests that patients with UUS harboring\n                    <jats:italic>SMARCA4<\/jats:italic>\n                    and\n                    <jats:italic>SMARCA2<\/jats:italic>\n                    co-deficiency may derive a survival benefit from early diagnosis and surgical resection. However, owing to the extreme rarity of UUS with co-deficiency of\n                    <jats:italic>SMARCA4<\/jats:italic>\n                    and\n                    <jats:italic>SMARCA2<\/jats:italic>\n                    , conducting a high-level phase III randomized controlled trial to validate this observation remains impractical.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1939651","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:39:00Z","timestamp":1790915940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage IA undifferentiated uterine sarcoma with SMARCA4 and SMARCA2 co-deficiency: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Rong","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Shaoxing Second Hospital, Shaoxing","place":["Zhejiang, China"]},{"name":"School of Medicine, Shaoxing University, Shaoxing","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialin","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, Shaoxing University, Shaoxing","place":["Zhejiang, China"]},{"name":"Department of Oncology, Shaoxing People\u2019s Hospital, Shaoxing","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lang","sequence":"additional","affiliation":[{"name":"School of Medicine, Shaoxing University, Shaoxing","place":["Zhejiang, China"]},{"name":"Department of Pathology, Shaoxing People\u2019s Hospital, Shaoxing","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkui","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shaoxing Second Hospital, Shaoxing","place":["Zhejiang, China"]},{"name":"School of Medicine, Shaoxing University, Shaoxing","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/gpm-24-15","article-title":"Management and prognosis of uterine sarcoma in elderly","volume":"7","author":"Gorostidi","year":"2024","journal-title":"Gynecol Pelvic Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/ogx.0000000000001513","article-title":"Uterine sarcomas: Clinical management and a review of systemic therapy","volume":"81","author":"Kouri","year":"2026","journal-title":"Obstet Gynecol Surv"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837004","article-title":"High-grade endometrial stromal sarcoma: Molecular alterations and potential immunotherapeutic strategies","volume":"13","author":"Kim","year":"2022","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17111893","article-title":"Endometrial stromal sarcoma: An update","volume":"17","author":"Ricotta","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ygyno.2023.02.009","article-title":"Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes","volume":"171","author":"Gadducci","year":"2023","journal-title":"Gynecol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-45654-1_7","article-title":"The SWI\/SNF complex: A frequently mutated chromatin remodeling complex in cancer","volume":"190","author":"Nguyen","year":"2023","journal-title":"Cancer Treat Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/his.15411","article-title":"Prognostic values of molecular subtypes and SWI\/SNF protein expression in de-differentiated\/undifferentiated endometrial carcinoma","volume":"86","author":"Shin","year":"2025","journal-title":"Histopathology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa227","article-title":"SWI\/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity","volume":"29","author":"Reske","year":"2020","journal-title":"Hum Mol Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206451","article-title":"SMARCA family of genes","volume":"73","author":"Chetty","year":"2020","journal-title":"J Clin Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.101793","article-title":"SMARCA4-deficient uterine sarcoma","volume":"35","author":"Yuan","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13000-023-01347-3","article-title":"Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma","volume":"18","author":"Gao","year":"2023","journal-title":"Diagn Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217282","article-title":"SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling","volume":"605","author":"Field","year":"2024","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1038\/s41467-023-38594-3","article-title":"Alanine supplementation exploits glutamine dependency induced by SMARCA4\/2-loss","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2026.03.012","article-title":"Molecular and clinicopathological characterisation of SMARCA4-deficient uterine tumours: distinguishing features between dedifferentiated\/undifferentiated endometrial carcinoma and undifferentiated uterine sarcoma","volume":"58","author":"Zheng","year":"2026","journal-title":"Pathology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12957-024-03610-3","article-title":"Undifferentiated uterine sarcoma : experience of a single center","volume":"22","author":"Yuan","year":"2024","journal-title":"World J Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.07.002","article-title":"Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group","volume":"176","author":"Kikuchi","year":"2023","journal-title":"Gynecol Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","article-title":"SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria","volume":"12","author":"Xue","year":"2021","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2026.101349","article-title":"EZH1\/2 inhibition selectively targets SMARCA4\/2 co-deficient lung cancer cells by suppressing stemness and proliferation","volume":"80","author":"Lee","year":"2026","journal-title":"Neoplasia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-026-01350-z","article-title":"SMARCA4\/2 loss reduces BCL-xL expression and confers a druggable MCL1 dependency in cancer","volume":"10","author":"Jiang","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-111523-023434","article-title":"Molecular pathogenesis of uterine sarcomas: Mechanisms and implications for treatment","volume":"21","author":"Chiang","year":"2026","journal-title":"Annu Rev Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_741_22","article-title":"Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature","volume":"20","author":"Verma","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18091415","article-title":"Mapping metastatic spread in uterine sarcoma: A population-based analysis of first metastatic patterns and outcomes","volume":"18","author":"Gennari","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18111689","article-title":"Subtype-specific prognosis, recurrence patterns, and molecular features in 148 Chinese uterine sarcomas: A real-world study","volume":"18","author":"Huang","year":"2026","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1186\/s12885-022-10129-x","article-title":"Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-21-0433","article-title":"SMARCA4: Implications of an altered chromatin-remodeling gene for cancer development and therapy","volume":"20","author":"Mardinian","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.14740\/jocmr6360","article-title":"Clinicopathologic and immunohistochemical correlates of disease-free survival in endometrial stromal sarcomas: A multicenter retrospective study from 2017 to 2025","volume":"18","author":"Barbakadze","year":"2026","journal-title":"J Clin Med Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/ijgc-2022-004204","article-title":"Prognostic factors in patients with uterine sarcoma: the SARCUT study","volume":"33","author":"Zapardiel","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12957-024-03376-8","article-title":"Sarcoma of the uterine cervix: experience of a single center","volume":"22","author":"Yuan","year":"2024","journal-title":"World J Surg Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217811","article-title":"SMARCA4: Promises and challenges in the treatment of cancers","volume":"625","author":"Ye","year":"2025","journal-title":"Cancer Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06515-2","article-title":"Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis","volume":"307","author":"Huss","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.39773","article-title":"A real-world study on diagnosis and treatment of uterine sarcoma in Western China","volume":"16","author":"Li","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","article-title":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients","volume":"11","author":"Fernando","year":"2020","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.13.681937","article-title":"Shifted assembly and function of mSWI\/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas","volume":"57","author":"St Laurent","year":"2025","journal-title":"Nat Genet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1939651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:39:06Z","timestamp":1790915946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1939651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":33,"alternative-id":["10.3389\/fonc.2026.1939651"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1939651","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1939651"}}